X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs FDC LTD. - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA FDC LTD. SUN PHARMA/
FDC LTD.
 
P/E (TTM) x 16.7 18.7 89.3% View Chart
P/BV x 3.4 3.9 86.4% View Chart
Dividend Yield % 0.7 1.2 56.2%  

Financials

 SUN PHARMA   FDC LTD.
EQUITY SHARE DATA
    SUN PHARMA
Mar-17
FDC LTD.
Mar-14
SUN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs842144 586.8%   
Low Rs57279 724.6%   
Sales per share (Unadj.) Rs131.647.6 276.7%  
Earnings per share (Unadj.) Rs32.77.6 429.8%  
Cash flow per share (Unadj.) Rs38.09.0 421.5%  
Dividends per share (Unadj.) Rs3.502.25 155.6%  
Dividend yield (eoy) %0.52.0 24.5%  
Book value per share (Unadj.) Rs152.747.5 321.3%  
Shares outstanding (eoy) m2,399.26177.83 1,349.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x5.42.3 229.7%   
Avg P/E ratio x21.614.6 147.9%  
P/CF ratio (eoy) x18.612.3 150.8%  
Price / Book Value ratio x4.62.3 197.9%  
Dividend payout %10.729.6 36.2%   
Avg Mkt Cap Rs m1,696,87719,784 8,577.2%   
No. of employees `00017.5NA-   
Total wages/salary Rs m49,0231,221 4,016.6%   
Avg. sales/employee Rs Th18,028.3NM-  
Avg. wages/employee Rs Th2,798.8NM-  
Avg. net profit/employee Rs Th4,479.5NM-  
INCOME DATA
Net Sales Rs m315,7848,459 3,733.3%  
Other income Rs m6,232394 1,583.4%   
Total revenues Rs m322,0168,852 3,637.8%   
Gross profit Rs m100,8932,070 4,873.7%  
Depreciation Rs m12,648249 5,077.3%   
Interest Rs m3,99831 12,892.6%   
Profit before tax Rs m90,4792,184 4,143.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m99-225 -44.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,116606 2,000.8%   
Profit after tax Rs m78,4621,353 5,798.5%  
Gross profit margin %31.924.5 130.5%  
Effective tax rate %13.427.7 48.3%   
Net profit margin %24.816.0 155.3%  
BALANCE SHEET DATA
Current assets Rs m329,5374,355 7,566.3%   
Current liabilities Rs m178,8701,792 9,982.2%   
Net working cap to sales %47.730.3 157.4%  
Current ratio x1.82.4 75.8%  
Inventory Days Days7944 177.7%  
Debtors Days Days8325 337.5%  
Net fixed assets Rs m204,7663,025 6,769.1%   
Share capital Rs m2,399179 1,343.4%   
"Free" reserves Rs m363,9978,243 4,416.1%   
Net worth Rs m366,3978,453 4,334.5%   
Long term debt Rs m14,36111 134,213.1%   
Total assets Rs m614,10210,557 5,817.0%  
Interest coverage x23.671.4 33.1%   
Debt to equity ratio x00 3,096.4%  
Sales to assets ratio x0.50.8 64.2%   
Return on assets %13.413.1 102.4%  
Return on equity %21.416.0 133.8%  
Return on capital %24.823.5 105.7%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m44,1181,146 3,849.4%   
Fx outflow Rs m24,484355 6,891.1%   
Net fx Rs m19,634791 2,482.8%   
CASH FLOW
From Operations Rs m70,8221,485 4,769.5%  
From Investments Rs m-42,216-620 6,814.5%  
From Financial Activity Rs m-22,854-753 3,037.1%  
Net Cashflow Rs m6,107113 5,413.7%  

Share Holding

Indian Promoters % 63.7 68.9 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 4.7 109.1%  
FIIs % 23.0 7.5 306.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 19.0 43.7%  
Shareholders   133,026 23,730 560.6%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week; Realty & Metal Stocks Plunge(Closing)

Indian share markets continued to languish in red in the afternoon session as rupee hit its weakest point since early April amid concerns.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Sep 22, 2017 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - PIRAMAL ENTERPRISES COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS